Article
[Human papillomavirus genotype profile in Kinshasa, Democratic Republic of the Congo: implications for vaccination].
Medecine tropicale : revue du Corps de sante colonial - 1 Dec 2008
Ali-Risasi C, Praet M, Van Renterghem L, Zinga-Ilunga B, Sengeyi D, Lokomba V, Mukamina L, Ndarabu A, Kayembe N N, Tshilolo L, Mukumbi M H
Abstract excerpt
UNLABELLED: Proposed anti-human papillomavirus (HPV) vaccines, i.e., Cervarix (Glaxomith-Kline) and Gardasil (Merck), are designed to prevent infection by two high-risk HPV types, i.e., 16 and 18, for which estimation mainly in Western Europe and North America have demonstrated a prevalence 60 to 70%. OBJECTIVE: The purpose of this study was to determine the genotype profile of HPV strains encountered in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
